Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jun 4, 2010 (rev. 1)

Premium

Genstruct has appointed David de Graaf as its chief scientific officer.

De Graaf most recently served as vice president of biotherapeutics and integrative biology at Boehringer-Ingelheim. Prior to that, he was director of systems biology at Pfizer and built the first systems biology team at AstraZeneca.

Before his career in industry, de Graaf was a researcher at the Weizmann Institute of Science and the Center for Genome Research at Whitehead/MIT.

Filed under

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.